Added to YB: 2026-07-15
Pitch date: 2026-07-13
BHST [neutral]
BioHarvest Sciences Inc.
-2.11%
current return
Author Info
Contrarian Cashflows publishes a monthly deep dive on a new value stock. Sign up for the newsletter.
Company Info
BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through two segments: Products and CDMO Services.
Market Cap
$62.8M
Pitch Price
$2.85
Price Target
N/A
Dividend
N/A
EV/EBITDA
-14.04
P/E
-4.78
EV/Sales
1.61
Sector
Personal Care Products
Category
value
Monday Delight: 13/07/2026 - BioHarvest Sciences Inc.
BHST (quick overview): Biotech using botanical cell culture to produce plant compounds (resveratrol) for nutraceutical/pharma. MC $66M, EV $59.8M, 1.7x EV/rev. Speculative wellness play: if scales to $100M rev at 20% EBITDA margin, only 3.5x EV/EBITDA vs CDMO peers mid-high teens. ~$100M facility replacement cost.
Read full article (1 min)